658 related articles for article (PubMed ID: 24815805)
1. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
Muthuri SG; Venkatesan S; Myles PR; Leonardi-Bee J; Al Khuwaitir TS; Al Mamun A; Anovadiya AP; Azziz-Baumgartner E; Báez C; Bassetti M; Beovic B; Bertisch B; Bonmarin I; Booy R; Borja-Aburto VH; Burgmann H; Cao B; Carratala J; Denholm JT; Dominguez SR; Duarte PA; Dubnov-Raz G; Echavarria M; Fanella S; Gao Z; Gérardin P; Giannella M; Gubbels S; Herberg J; Iglesias AL; Hoger PH; Hu X; Islam QT; Jiménez MF; Kandeel A; Keijzers G; Khalili H; Knight M; Kudo K; Kusznierz G; Kuzman I; Kwan AM; Amine IL; Langenegger E; Lankarani KB; Leo YS; Linko R; Liu P; Madanat F; Mayo-Montero E; McGeer A; Memish Z; Metan G; Mickiene A; Mikić D; Mohn KG; Moradi A; Nymadawa P; Oliva ME; Ozkan M; Parekh D; Paul M; Polack FP; Rath BA; Rodríguez AH; Sarrouf EB; Seale AC; Sertogullarindan B; Siqueira MM; Skręt-Magierło J; Stephan F; Talarek E; Tang JW; To KK; Torres A; Törün SH; Tran D; Uyeki TM; Van Zwol A; Vaudry W; Vidmar T; Yokota RT; Zarogoulidis P; ; Nguyen-Van-Tam JS
Lancet Respir Med; 2014 May; 2(5):395-404. PubMed ID: 24815805
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data.
Heneghan CJ; Onakpoya I; Jones MA; Doshi P; Del Mar CB; Hama R; Thompson MJ; Spencer EA; Mahtani KR; Nunan D; Howick J; Jefferson T
Health Technol Assess; 2016 May; 20(42):1-242. PubMed ID: 27246259
[TBL] [Abstract][Full Text] [Related]
3. Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
Venkatesan S; Myles PR; Bolton KJ; Muthuri SG; Al Khuwaitir T; Anovadiya AP; Azziz-Baumgartner E; Bajjou T; Bassetti M; Beovic B; Bertisch B; Bonmarin I; Booy R; Borja-Aburto VH; Burgmann H; Cao B; Carratala J; Chinbayar T; Cilloniz C; Denholm JT; Dominguez SR; Duarte PAD; Dubnov-Raz G; Fanella S; Gao Z; Gérardin P; Giannella M; Gubbels S; Herberg J; Higuera Iglesias AL; Hoeger PH; Hu XY; Islam QT; Jiménez MF; Keijzers G; Khalili H; Kusznierz G; Kuzman I; Langenegger E; Lankarani KB; Leo YS; Libster RP; Linko R; Madanat F; Maltezos E; Mamun A; Manabe T; Metan G; Mickiene A; Mikić D; Mohn KGI; Oliva ME; Ozkan M; Parekh D; Paul M; Rath BA; Refaey S; Rodríguez AH; Sertogullarindan B; Skręt-Magierło J; Somer A; Talarek E; Tang JW; To K; Tran D; Uyeki TM; Vaudry W; Vidmar T; Zarogoulidis P; ; Nguyen-Van-Tam JS
J Infect Dis; 2020 Jan; 221(3):356-366. PubMed ID: 31314899
[TBL] [Abstract][Full Text] [Related]
4. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.
Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
PLoS One; 2012; 7(9):e43491. PubMed ID: 22984431
[TBL] [Abstract][Full Text] [Related]
5. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).
Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD002744. PubMed ID: 22513907
[TBL] [Abstract][Full Text] [Related]
6. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.
Muthuri SG; Venkatesan S; Myles PR; Leonardi-Bee J; Lim WS; Al Mamun A; Anovadiya AP; Araújo WN; Azziz-Baumgartner E; Báez C; Bantar C; Barhoush MM; Bassetti M; Beovic B; Bingisser R; Bonmarin I; Borja-Aburto VH; Cao B; Carratala J; Cuezzo MR; Denholm JT; Dominguez SR; Duarte PA; Dubnov-Raz G; Echavarria M; Fanella S; Fraser J; Gao Z; Gérardin P; Giannella M; Gubbels S; Herberg J; Higuera Iglesias AL; Hoeger PH; Hoffmann M; Hu X; Islam QT; Jiménez MF; Kandeel A; Keijzers G; Khalili H; Khandaker G; Knight M; Kusznierz G; Kuzman I; Kwan AM; Lahlou Amine I; Langenegger E; Lankarani KB; Leo YS; Linko R; Liu P; Madanat F; Manabe T; Mayo-Montero E; McGeer A; Memish ZA; Metan G; Mikić D; Mohn KG; Moradi A; Nymadawa P; Ozbay B; Ozkan M; Parekh D; Paul M; Poeppl W; Polack FP; Rath BA; Rodríguez AH; Siqueira MM; Skręt-Magierło J; Talarek E; Tang JW; Torres A; Törün SH; Tran D; Uyeki TM; van Zwol A; Vaudry W; Velyvyte D; Vidmar T; Zarogoulidis P; ; Nguyen-Van-Tam JS
Influenza Other Respir Viruses; 2016 May; 10(3):192-204. PubMed ID: 26602067
[TBL] [Abstract][Full Text] [Related]
7. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.
Shun-Shin M; Thompson M; Heneghan C; Perera R; Harnden A; Mant D
BMJ; 2009 Aug; 339():b3172. PubMed ID: 19666987
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase inhibitors for preventing and treating influenza in children.
Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
[TBL] [Abstract][Full Text] [Related]
11. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.
Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
Influenza Other Respir Viruses; 2013 Sep; 7 Suppl 2(Suppl 2):82-86. PubMed ID: 24034490
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of neuraminidase inhibitors for severe influenza.
Fry AM
Lancet Respir Med; 2014 May; 2(5):346-8. PubMed ID: 24815800
[No Abstract] [Full Text] [Related]
13. Effectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada.
Marra F; Chong M; Henry B; Patrick DM; Kendall P
J Antimicrob Chemother; 2014 May; 69(5):1397-406. PubMed ID: 24346762
[TBL] [Abstract][Full Text] [Related]
14. Neuraminidase inhibitors for critically ill children with influenza.
Louie JK; Yang S; Samuel MC; Uyeki TM; Schechter R
Pediatrics; 2013 Dec; 132(6):e1539-45. PubMed ID: 24276847
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ
Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
Mawatari M; Saito R; Hibino A; Kondo H; Yagami R; Odagiri T; Tanabe I; Shobugawa Y;
PLoS One; 2019; 14(11):e0224683. PubMed ID: 31697721
[TBL] [Abstract][Full Text] [Related]
17. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
Wolkewitz M; Schumacher M
Lancet Respir Med; 2014 Jul; 2(7):e8-9. PubMed ID: 24948434
[No Abstract] [Full Text] [Related]
18. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
Leonardi-Bee J; Venkatesan S; Muthuri SG; Nguyen-Van-Tam JS; Myles PR;
Lancet Respir Med; 2014 Jul; 2(7):e10-2. PubMed ID: 24948433
[No Abstract] [Full Text] [Related]
19. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
Jones M; Del Mar C; Hama R
Lancet Respir Med; 2014 Jul; 2(7):e9-e10. PubMed ID: 24948431
[No Abstract] [Full Text] [Related]
20. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
Antes G; Meerpohl JJ
Lancet Respir Med; 2014 Jul; 2(7):e10. PubMed ID: 24948429
[No Abstract] [Full Text] [Related]
[Next] [New Search]
